Today: 7 lutego 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3-pl- Page 294

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price on 19 November 2025 As of late Wednesday trading, Boston Scientific stock was changing hands at around $96.6, down roughly 2.6% on the day. Intraday, BSX has traded in a range of roughly $96–$100, with volume running in the high single‑digit millions of shares.Investing.com Recent price action shows a short losing streak: BSX closed at about $99.2 on Tuesday (‑2.5%),
19 listopada 2025
Target Shocks Workers: 1,000 HQ Jobs Cut Before Christmas – Retail Giant’s Woes Deepen

Target (TGT) Q3 2025 Earnings: EPS Beat, Sales Miss and Holiday Price War Weigh on the Stock

Target Corporation (NYSE: TGT) reported third‑quarter 2025 results today, November 19, posting better‑than‑expected earnings per share but another decline in sales as cautious U.S. shoppers traded down and pulled back on discretionary purchases. Revenue came in slightly below Wall Street forecasts, and shares fell in response, even as management rolled out aggressive holiday discounts and a larger investment plan to revive growth. Target Corporation+2Reuters+2 As of early afternoon U.S. trading, TGT stock was hovering in the mid‑$80s, down roughly 2–3% on the day, after dropping more than 3% in pre‑market trading following the release. Investing.com+1 Target Q3 2025 Earnings at a Glance
19 listopada 2025
··
Nvidia’s Meteoric October: $4 Trillion Milestone, Mega AI Deals, and Unstoppable Momentum

Nvidia Q3 2026 Earnings: Record $57 Billion Revenue as AI Chip Demand Supercharges Data Center Business

Published: November 19, 2025 Nvidia has once again rewritten the record books. On Wednesday, the AI chip leader reported third-quarter fiscal 2026 results that smashed Wall Street expectations, powered by soaring demand for its data center GPUs used to train and run artificial intelligence models. Revenue hit a record $57.0 billion, up 22% quarter over quarter and 62% year over year, with profit and guidance both coming in ahead of forecasts.NVIDIA Newsroom+1 After the report, Nvidia shares jumped in after-hours trading, adding to a rally into the close as investors cheered another blowout AI quarter.Kiplinger Key Numbers From Nvidia’s Q3 FY2026 For the fiscal quarter
19 listopada 2025
····
NVIDIA’s Stock Soars to New Highs – Analysts Eye Further Gains

Nvidia Stock Today (NVDA) on November 19, 2025: Shares Jump After Record $57 Billion Q3 Revenue and Bullish AI Outlook

Published: November 19, 2025 Nvidia stock took center stage on Wall Street today as the AI chip giant delivered another blockbuster earnings report and signaled that demand for its GPUs is still accelerating, not cooling. After a volatile few weeks marked by talk of an “AI bubble,” Nvidia’s results for its fiscal third quarter of 2026 and its strong outlook helped push NVDA higher in both regular and after-hours trading, while calming broader market jitters. ABC17NEWS+1 Nvidia stock price today: how NVDA traded on November 19, 2025 During Wednesday’s regular session, Nvidia (NASDAQ: NVDA) gained just under 3%, closing at $186.52. The
20 listopada 2025
··
MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre, Inc. (NASDAQ: MELI) is back in the spotlight today, 20 November 2025, as its share price slides sharply even while new filings show fresh institutional buying and a recently filed mixed shelf registration reshapes expectations for the Latin American e‑commerce giant’s next growth phase. Below is a breakdown of the key MercadoLibre news and market action specifically dated 20 November 2025, plus the broader context investors are watching. MercadoLibre stock on 20 November 2025: Pullback deepens near support After a strong multi‑year run, MELI stock is decisively on the back foot today. According to MarketScreener’s Nasdaq data, MercadoLibre shares
20 listopada 2025
·
Coca-Cola (KO) Stock: 7 Surprising Facts You Need to Know (Oct 11, 2025)

Coca-Cola Stock (KO) Today: Price, Fresh Analyst Calls and Key News on November 21, 2025

Published: November 21, 2025 – All figures as of market trading on this date. Coca-Cola stock today: near highs with fresh momentum Coca-Cola stock (NYSE: KO) is trading around $73 per share in Friday’s session, up roughly 2–2.5% from Thursday’s close of $71.21.StockAnalysis+1 That puts the beverage giant within touching distance of its 52‑week high of $74.38, and well above its 12‑month low of $60.62.StockAnalysis+1 Over the last year, Coca-Cola has delivered about 15% total shareholder return, including dividends, and is up just over 15% year to date, underscoring its role as a defensive winner in a choppy market.Simply Wall
21 listopada 2025
·
Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk stock is back in the spotlight today, 21 November 2025, as a cluster of breaking headlines hits the world’s most closely watched weight‑loss drug maker. As of late morning in New York, Novo Nordisk’s U.S. ADR (NYSE: NVO) is trading around $47.07, down roughly 1.1% on the day, giving the company a market value close to $213 billion. In Copenhagen, Novo Nordisk’s B‑shares finished the session around DKK 305, down nearly 3% and extending a steep slide that has left the stock down about 45% year‑to‑date. Investing.com+1 Today’s trading comes against a flurry of fresh news: Below is
21 listopada 2025
···
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics stock is one of those tickers that still pops up on certain quote screens in late 2025 – but in reality, it isn’t a “normal” stock anymore. As of Sunday, November 23, 2025, NeuBase is a dissolved biotech in legal wind‑down, its common shares delisted and largely cashed out through liquidation payments and a non‑tradable escrow structure. MarketWatch+1 Below is a deep, investor‑focused look at what NBSE actually represents today, what happened in 2024–2025, and what, if anything, existing shareholders can still reasonably expect. Key takeaways for NBSE on November 23, 2025 Where NeuBase stands today (Sunday, November
23 listopada 2025
·
1 … 292 293 294

Stock Market Today

Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Akcje Salesforce próbują się ustabilizować po „softwarowej apokalipsie” AI — wyniki za 25 lutego będą kolejnym testem

7 lutego 2026
Akcje Salesforce spadły w tym tygodniu o 9%, kończąc piątkową sesję na poziomie 190,07 USD po wcześniejszych wahaniach. W czwartek sektor software zanotował gwałtowny spadek, a indeks S&P 500 software and services stracił 4,6%. Inwestorzy obawiają się, że szybki rozwój narzędzi AI może ograniczyć wzrost przychodów z modelu SaaS. Salesforce opublikuje wyniki 25 lutego.
Go toTop